Inhibitory action of phytate on hydroxyapatite precipitation induced by 58S bioactive glass
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone and Dental Protein Studies · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Pathological calcification of biomaterials
2. Phytate intake, health and disease: “let thy food Be thy medicine and medicine Be thy food10.3390/antiox12010146 ↗
3. W.J. Jr, W.F. Bergfeld, D.V. Belsito, R.A. Hill, C.D. Klaassen, D.C. Liebler, J.G.M. Jr, R.C. Shank, T.J. Slaga, P.W. Snyder, M. Fiume, B. Heldreth, Safety assessment of polyol phosphates as used in cosmetics, 43 (2024) 78–107. https://doi.org/10.1177/10915818241259699.10.1177/10915818241259699 ↗
4. The relevance of phytate for the treatment of chronic kidney disease10.2215/CJN.0000000000000558 ↗
5. Phytic acid interactions in food systems10.1080/10408398009527293 ↗
6. Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones : pilot study10.1007/s00240-022-01357-8 ↗
7. Estimated phytate intake is associated with bone mineral density in Mediterranean postmenopausal women10.3390/nu15071791 ↗
8. Role of myoinositol hexaphosphate (SNF 472) in calciphylaxis: an update10.1111/1744-9987.13817 ↗
9. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels10.1007/s40620-018-0471-9 ↗
10. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats10.2741/1786 ↗
11. Phytate inhibits bovine pericardium calcification in vitro10.1016/j.carpath.2007.08.005 ↗
12. SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification
13. Reprint of: review of bioactive glass: from Hench to hybrids10.1016/j.actbio.2015.07.019 ↗
14. A review on bioactive glass, its modifications and applications in healthcare sectors10.1016/j.jnoncrysol.2023.122404 ↗
15. Role of bioglass derivatives in tissue regeneration and repair: a review
16. A. Skwira, A. Szewczyk, M. Prokopowicz, Bioglass obtained via one-pot synthesis as osseointegrative drug delivery system, 633 (2023). https://doi.org/10.1016/j.ijpharm.2023.122610.10.1016/j.ijpharm.2023.122610 ↗
17. Bioceramics: a review on design concepts toward tailor-made (multi)-functional materials for tissue engineering applications10.1007/s10853-023-08226-8 ↗
18. Applications of different bioactive glass and glass-ceramic materials for osteoconductivity and osteoinductivity10.1080/0371750X.2017.1360799 ↗
19. Bioactive glasses: importance of structure and properties in bone regeneration10.1016/j.molstruc.2014.03.066 ↗
20. Biologically-engineered mechanical model of a calcified artery10.1016/j.actbio.2020.04.018 ↗
21. The effect of bioactive glasses on bone marrow stromal cells differentiation10.1016/j.biomaterials.2004.09.059 ↗
22. Inositol hexaphosphate in bone health and disease10.3390/biom14091072 ↗
23. SNF472 : a novel therapeutic agent for vascular calcification and calciphylaxis10.1007/s40620-024-01909-8 ↗
24. Biomineralization of calcium phosphate revealed by in situ liquid-phase electron microscopy10.1038/s42004-018-0081-4 ↗
25. Review and the state of the art: sol–gel and melt quenched bioactive glasses for tissue engineering10.1002/jbm.b.33443 ↗
26. The role of calcium nitrate in early crystallization of hydroxyapatite and its effects on the bioactivity and protein adsorption of a 58S glass10.1016/j.jnoncrysol.2024.123036 ↗
27. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
28. Toward a detailed understanding of magnesium ions on hydroxyapatite crystallization inhibition10.1021/cg401619s ↗
29. Line profiles of neutron powder-diffraction peaks for structure refinement10.1107/S0365110X67000234 ↗
30. Young · 1993
31. Modelling the silica glass structure by the Rietveld method10.1016/0022-3093(94)00664-4 ↗
32. Description and survey of methodologies for the determination of amorphous content via X-ray powder diffraction10.1524/zkri.2011.1437 ↗
33. Eichert · 2009
34. Ordering in sol-gel-derived bioactive glasses and its influence on the dissolution/precipitation behavior in a complex culture medium10.1016/j.jnoncrysol.2018.04.054 ↗
35. Nanocrystalline apatite formation on bioactive glass in a sol–gel synthesis10.1016/j.jnoncrysol.2016.02.013 ↗
36. Cell-free and cell-based approaches for bone regeneration10.1038/nrrheum.2009.228 ↗
37. Calcium carbonate: adored and ignored in bioactivity assessment10.1016/j.actbio.2019.04.039 ↗
38. Calcium orthophosphates in nature, biology and medicine10.3390/ma2020399 ↗
39. Calcium phosphate bone cements for clinical applications. Part I: solution chemistry10.1023/A:1008937507714 ↗
40. A crystal-clear view10.1038/nmat2911 ↗
41. The role of prenucleation clusters in surface-induced calcium phosphate crystallization10.1038/nmat2900 ↗
42. Insight by Cryo-TEM into the growth and crystallization processes of calcium phosphate nanoparticles in aqueous medium10.1016/j.matchemphys.2019.121862 ↗
43. Synthetic amorphous calcium phosphate and its relation to bone mineral structure10.1021/ar50092a003 ↗
44. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis10.1111/bph.15163 ↗
45. Calcium binding to phytic acid10.1021/jf00118a045 ↗
46. Phytic acid-metal ion interactions. II. The effect of pH on ca(II) binding10.1016/0162-0134(86)80105-2 ↗
47. Transformation of amorphous calcium phosphate to bone-like apatite10.1038/s41467-018-06570-x ↗
48. First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification10.1111/bcp.13752 ↗